These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22374326)

  • 1. Influence of myeloperoxidase-catalyzing reaction on the binding between myeloperoxidase and anti-myeloperoxidase antibodies.
    Xu PC; Hao J; Chen M; Cui Z; Zhao MH
    Hum Immunol; 2012 Apr; 73(4):364-9. PubMed ID: 22374326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass.
    Xu PC; Chen M; Zhao MH
    Autoimmunity; 2012 May; 45(3):218-25. PubMed ID: 21875381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.
    Xu PC; Cui Z; Chen M; Hellmark T; Zhao MH
    Rheumatology (Oxford); 2011 Jul; 50(7):1236-43. PubMed ID: 21372002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
    Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
    Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.
    Ye H; Gao Y; Guo XH; Zhao MH
    Clin Exp Immunol; 2005 Oct; 142(1):116-9. PubMed ID: 16178864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis.
    Xu PC; Chen M; Cui Z; Zhao MH
    Rheumatology (Oxford); 2010 Nov; 49(11):2068-75. PubMed ID: 20675709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of oxidative activity of myeloperoxidase by anti-myeloperoxidase antibodies from patients with microscopic polyangiitis].
    Chen J; Chen M; Liu Zs; Zhao Mh
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):155-9. PubMed ID: 18458690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
    Fiebeler A; Borgmann S; Woywodt A; Haller H; Haubitz M
    Nephrol Dial Transplant; 2004 Apr; 19(4):969-71. PubMed ID: 15031357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan's syndrome].
    Suzuki M; Arimura Y; Minoshima S; Fukuoka K; Miyake N; Ishizuka S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1996 Sep; 38(9):423-7. PubMed ID: 8913096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
    Almroth G; Berlin G; Andersson B; Hahn-Zoric M
    Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.